Author's details
- Dr. Khashau Eleburuike
- MBBS (Ilorin) MSc. Global Health Karolinska Institute.
- Resident doctor in family medicine in Northern Sweden.
Reviewer's details
- Dr. Gboyega Olarinoye
- MBBS, FMCP.
- Dermatologist FMC Keffi Nassarawa State. Nigeria
Leishmaniasis
Background
Leishmaniasis in darker-skinned individuals often presents as skin ulcers that may appear as dark, scarred lesions, and is caused by the *Leishmania* parasite transmitted through the bite of infected sandflies. The cutaneous form of leishmaniasis is the most common and can result in disfiguring scarring, particularly in areas such as the face, hands, and legs. Treatment involves antiparasitic medications such as sodium stibogluconate or liposomal amphotericin B, and in some cases, local therapy or cryotherapy may be used to manage smaller lesions.
Lesion image
References
- @article{Mawenzi2018ACO, {A case of cutaneous leishmaniasis successfully treated with oral terbinafine in Kenya}, author={Ramadhan L. Mawenzi}, journal={International Journal of Research in Dermatology}, year={2018}, url={https://api.semanticscholar.org/CorpusID:55567292}
- Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Research. 2017;6.
- Hepburn NC. Cutaneous leishmaniasis. Clinical and experimental dermatology. 2000 Sep 1;25(5):363-70.
